Authors: Aaron R. Kaufman, Shawn Gulati, John H. Pula, Timothy M. Janetos, Neena R. Cherayil, Eric Chiu, Emily Anne Shepherd, Karl C. Golnik, Enrique Garcia-Valenzuela, Peter W. MacIntosh, Brooke T. Johnson, Kimberlee M. Curnyn

Contributors: Department of Ophthalmology and Visual Sciences (ARK, SG, PWM, BTJ, KMC), Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois, NorthShore University Health System (JHP), Evanston, Illinois, Department of Ophthalmology (TMJ, NRC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois, Department of Neurology (NRC), Feinberg School of Medicine, Northwestern University, Chicago, Illinois, Des Peres Eye Center (EC), Des Peres, Missouri, Department of Ophthalmology (EAS), Rush University Medical Center, Chicago, Illinois, Department of Ophthalmology (KCG), University of Cincinnati College of Medicine (KCG), Cincinnati, Ohio, Cincinnati Eye Institute (KCG), Cincinnati, Ohio, and Midwest Retina Consultants (EG-V), Arlington Heights, Illinois

Superior Title: Journal of Neuro-Ophthalmology, December 2022, Volume 42, Issue 4

Subject Terms: Adolescent, Anisocoria / drug therapy, Cholinergic Antagonists / adverse effects, Female, Humans, Male, Mydriasis / chemically induced, Mydriasis / diagnosis, Mydriasis / drug therapy, Retrospective Studies

Relation: https://collections.lib.utah.edu/ark:/87278/s6dy471m

Availability: https://collections.lib.utah.edu/ark:/87278/s6dy471m